Siddhanta Pharma Gears Up to Meet Growing Demand with ₹50 Crore API Project

Siddhanta Pharma Private Limited is embarking on a significant expansion with the launch of a new Active Pharmaceutical Ingredients (API) project located at Chirakhan, Dhar in Madhya Pradesh. This initiative, with an investment of 50 crores, is set to significantly bolster the company's manufacturing capacity, aiming to produce 200 tons of APIs per month.

The project is strategically positioned to leverage advanced technologies in pharmaceutical production, aiming to meet the growing demand for high-quality APIs both domestically and internationally. This production boost is particularly crucial in the context of increasing reliance on essential medicines and the global push for more robust pharmaceutical supply chains.

State-of-the-art facilities are being constructed to ensure compliance with both national and international safety and quality standards. Siddhanta Pharma is committed to adopting environmentally sustainable practices, including waste reduction and energy-efficient operations, to minimize the environmental impact of its activities.

The increased production capacity is expected to not only enhance Siddhanta Pharma's market share but also contribute significantly to the local economy by creating job opportunities and fostering community development. This project is anticipated to set a benchmark in the region for future industrial projects in the pharmaceutical sector.

Upon completion, Siddhanta Pharma aims to become a key player in the API market, supporting the pharmaceutical industry's growth and ensuring a steady supply of critical ingredients that are fundamental to healthcare and medicine across the globe.

News by Rahul Yelligetti